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Abstract
Electrodermal activity (EDA) at acupuncture points (acupoints) has been investi-
gated for its utility as a diagnostic aid, a therapeutic monitoring tool, and a physio-
logical outcome measure. The research methodologies reported in published trials, 
however, vary considerably and publications often lack sufficient details about 
electrical instrumentation, technical procedures, laboratory conditions, recorded 
measures, and control comparisons to permit a critical appraisal of the studies or 
to replicate promising findings. We developed a 10-category (54 subitems) Quality 
of Reporting scale based on technical issues associated with EDA measurements, 
publication requirements for reporting EDA in the psychophysiological literature, 
and recommendations from the CONSORT Statement for reporting clinical trials. 
Using our Quality of Reporting scale, we extracted data from 29 studies that evaluated 
EDA at acupoints in patients and generated weighted scores for each of the 10 cat-
egories of essential information. Only 9 of the 29 studies reviewed scored a mean 
of greater than 50% for reporting details of essential information. To rigorously 
build a program of research on EDA at acupoints we need to standardize research 
methodology and reporting protocols. We propose a checklist of recommended 
informational items to report in future clinical trials that record EDA at acupoints.
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1.  Introduction
Electrodermal activity (EDA) at acupuncture points 
(acupoints) has been used by clinicians as a diag-
nostic aid and therapeutic monitoring tool for 
more than 50 years [1−4]. Recently, researchers 
have begun to explore EDA at acupoints as a poten-
tial physiological outcome measure for use in clini-
cal trials of acupuncture [5,6]. No clear guidelines, 
however, exist for conducting or reporting this type 
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of research. The instruments, techniques, and mea-
surement protocols that are used vary widely, and 
to date, neither the diagnostic validity of EDA re-
cordings at acupoints nor their utility as outcome 
measures has been definitely established.
This lack of standards or guidelines for con-
ducting and reporting EDA at acupoints research 
became obvious when we recently attempted to 
conduct a systematic review aimed at answering 
the question, “Is there evidence to support the use 
of EDA at acupoints as an aid to diagnosis and/or 
therapeutic monitoring?” Our review of 29 relevant 
studies [5,7−34] revealed not only that the quality 
of available studies is heterogeneous, but that 
what is being evaluated under the rubric of electro-
dermal testing is very diverse. The existing literature 
reveals marked dissimilarities in EDA at acupoints 
testing procedures, electrical parameters measured, 
measurement techniques, instruments, clinical ap-
proaches, medical conditions studied, outcomes, 
and statistical analyses. To move this program of re-
search forward, the careful conduct and detailed 
reporting of clinical trials involving measurements of 
EDA at acupoints is essential. It is only when the 
technical and procedural details of a study are fully 
reported that we can critically appraise, accurately 
interpret, and attempt to replicate outcomes.
Our specific objectives for this review are to 
summarize the EDA at acupoints literature, evalu-
ate the quality of reporting essential information 
in 29 clinical trials, and begin to define reporting 
guidelines for future studies. We will elaborate on 
10 domains of essential information and propose a 
checklist of 54 items that need to be addressed in 
EDA at acupoints research. We will also refer read-
ers to examples of good reporting from the reviewed 
literature. Our review does not include recom-
mendations for designing, conducting, or analyzing 
trials, but solely addresses adequacy of reporting.
2. Materials and Methods
2.1. Literature review
One author (K.S.) searched four electronic data-
bases (PubMed, AltHealthWatch, Scientific Citation, 
and AMED) from the time of inception through 
August 10, 2010, to identify clinical studies that in-
volved the evaluation of EDA at acupoints in hu-
mans. Various search strategies were employed 
depending on the size and scope of the database. 
In some cases, a simple keyword search using the 
terms “electrodermal” and “acupuncture” were 
sufficient to retrieve relevant articles. In other 
cases, a more sophisticated strategy involving mul-
tiple terms such as “electrical skin resistance,” 
“impedance,” “conductance,” “admittance,” and/
or “electric potential,” subject headings, truncation, 
and excluded terms was required. K.S. examined 
the results of the searches to identify articles for 
analysis, screening by title, abstract (when avail-
able), and full text where necessary. The bibliog-
raphies from relevant original research, reviews, and 
a key textbook [35] in the EDA field were searched 
to identify additional references.
2.2.  Inclusion/exclusion criteria
Studies were selected for inclusion using the fol-
lowing criteria. Publication type: Only English lan-
guage articles were included due to limited funding 
for accurate translation. Abstracts, posters, and 
editorials were excluded because they were unlikely 
to provide sufficient details about EDA parameters. 
Study design: Clinical trials, case series, case re-
ports, and observational studies were all included 
because our goal was to summarize and evaluate all 
available EDA at acupoints protocols. Electrical 
measurements: Only studies that measured the 
electrical characteristics of acupoints were included. 
Studies that reported conductance measurements 
in meridians or at trigger points were excluded. 
Clinical indication: We included studies involving 
any clinical diagnosis or medical condition in pa-
tients but excluded studies that evaluated physio-
logical changes in healthy volunteers.
2.3. Items for data extraction
Our list of essential data to be extracted was based 
on electrical parameters outlined in a review by 
Ahn and Martinsen [36] covering technical issues in 
electrodermal measurements at acupoints, psycho-
physiological research publication requirements for 
reporting EDA [37,38] and on the extended CONSORT 
statement for clinical trial reporting [39,40]. We 
defined 10 broad categories of information with 54 
subitems. Four evaluators used an iterative process 
to clarify and refine specific items in each infor-
mation category. Table 1 lists the final data items 
that were extracted from each study.
2.4.  Data extraction and scoring process
When the data extraction sheet was finalized, the 
29 identified articles were randomly distributed to 
four reviewers. Two reviewers evaluated each article, 
extracting and scoring data on a total of 54 items. 
A quality assurance (QA) score was developed to 
quantify how completely each item in the 10 cat-
egories was reported. Two points were given if 
an item was reported in enough detail to charac-
terize the clinical aspects and electrical parameters, 
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Table 1  Ten domains of essential information to be 
reported in trials involving measurements 
of electrodermal activity at acupuncture 
points
Essential  Subitem information extracted
information from each study
1. General •  Electrodermal Activity (EDA) 
  approach
 •  Medical diagnosis
 •  Acupuncture diagnosis
 •  Method of diagnosis
 •  Objectives
 •  Hypothesis
2. Subjects and •  No. of participants
 settings •  Method of recruitment
 •  Inclusion/exclusion criteria
 •  Randomization procedures
 •  Patient demographics
 •  Settings where data collected
3.  Skin site •  Bioactive point names
selection  and body locations
 •  Justification of bioactive point
 •  Point location by acupuncturist
  or operator 
 •  Training of acupuncturist or
  operator
4. Controls •  Participants, skin sites or
  substances
 •  Rationale for control chosen
 •  Timing of evaluation of controls
 •  Controls tested under same
  conditions
 •  Randomized order for testing
  controls
5.  Electrode •  Rationale for choice of electrode
system  system
 •  No. of electrodes
 •  Material of electrodes
 •  Size, geometry of electrodes
 •  Electrodes pretested
6. Confounding •  Probe/skin interface
 variables •  How probe/skin contact
  maintained
 •  Skin preparation technique
 •  Location of reference electrode
 •  Justification for location
  of reference electrode
 •  Material of reference electrode
 •  Skin surface described
 •  Pressure on probe electrode
 •  Skin moisture factors
 •  Contact impedance 
  polarization
 •  Physical movement
 •  Confounders with repeat 
  measurements 
7. Instrument/ •  Name of instrument,
 electrical  manufacturer contact 
 parameters  information
 •  How instrument works,
  manipulates signal
 •  Calibration/validation of 
  instrument
 •  Type of current and 
  rationale
 •  Amplitude of current
 •  Frequency of current
 •  Grounding for electric 
  potential measurements
 •  Input impedance for 
  electric potential 
  measurements
 8. Measurements •  Primary and secondary 
  outcome measures
 •  Clear what was being 
  measured
 •  No., frequency, and 
  duration of measurements
 •  Mathematical 
  manipulation of data 
  when applicable
 •  Account for temporal 
  variability, emotion, time 
  of day
 •  Test-retest reliability of 
  system
 •  Interuser reliability
 9. Blinding •  Blinding of participants, 
  operators, assessors
 •  Success of blinding
10.  Results/ •  Summary presentation of 
statistical  primary and secondary 
analysis  outcomes
 •  Statistical methods
permitting replication by other investigators. One 
point was given if the item was only partially de-
scribed but enough detail was given to make rea-
sonable inferences about that item. For example, 
if the electroacupuncture according to Voll (EAV) 
method [3,41] was named we assumed, although 
not clearly stated, that a direct current (DC) was 
applied to obtain electrical conductance measure-
ments. In this case one point was given for the item 
that requested “Type of current and Rationale.” 
One point was also given if, for example, the authors 
did not specifically state that control skin sites were 
assessed under the same conditions as active sites 
but described testing several sites that included 
both active and control points in one measurement 
session. Zero points were assigned if an essential 
informational item was not mentioned in the report. 
Not all categories of information were applicable to 
all studies. For example, information about ground-
ing and input impedance needed to be reported if 
electrical potentials were measured [42], but this 
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information was not applicable when DC resistance or 
conductance measurements were made. By contrast, 
when DC measurements were recorded a descrip-
tion of a DC return reference had to be included. 
A perfect QA score was 100% for the 10 categories.
3. Results
In this section we will summarize the quality of 
reporting each of the 10 information domains, 
(Figure 1), make recommendations for adequate 
reporting of essential information, and refer the 
reader to examples of appropriate reporting.
3.1.  General aspects of the study
3.1.1.  Approaches used to evaluate EDA at 
acupuncture points
Four main electrodermal testing approaches were 
used in the 29 studies: EAV (n = 10) [13,17,18,20, 
23,26,27,29,30,33], Auricular (n = 9) [9,10,21,22,
24,25,28,31,34], Ryodoraku (n = 6) [8,14−16,19,32], 
and Jing-well (n = 2) [5,12]. Additionally, in one study 
[7], disease specific meridian-relevant acupoints 
were measured and in another, 24 unnamed acu-
points on the hands and feet were assessed [11]. 
Each of these EDA testing approaches has its own 
historical development, theoretical underpinnings, 
instrumentation, acupoint selection, and clinical 
testing procedures. A brief description of each of the 
four main approaches follows.
EAV was developed by Reinhold Voll in the 1950s 
[2,3] and is summarized for modern acupuncturists 
in a publication by Tsuei [43]. EAV involves testing 
skin resistance at specific points, generally on the 
hands and feet. The electrodermal screening de-
vices (EDSD) used, consist of a direct current volt-
age source that delivers approximately 10−12 μA of 
DC current at 1−1.25 V, a reference electrode con-
tacting the patient some distance from the measure-
ment site, and a voltmeter to measure the voltage 
drop from the source to the reference electrode 
[43]. Electrical resistance is measured in kohms, 
converted to conductance (the reciprocal of resis-
tance) and reported in normalized units on a scale 
of 0−100. Readings are usually described with two 
values, the initial reading and the indicator drop. 
According to Voll’s theory, initial readings from 45 
to 55, followed by no indicator drop, are normal 
(“balanced”); conductance readings above 60 indi-
cate inflammation in the system associated with 
the point being tested; and readings below 45 sug-
gest organ stagnation and/or degeneration [43]. 
An indicator drop is considered the most important 
part of the EAV measurement and when found, the 
focus of EAV testing consists of evaluating the EDA 
response to the introduction of various substances 
(usually placed on a metal plate connected in the 
electrical circuit). Similarly, remedies for the pre-
sumed dysfunctions are tested to see if normal 
readings are restored by the introduction of a nu-
tritional, homeopathic, or other remedy. A typical 
examination may also include a four quadrant 
measurement (hand to hand, foot to foot, right 
hand to right foot, and left hand to left foot) to as-
sess whole body energy.
Of the 29 studies, 10 explicitly stated use of the 
EAV approach [13,17,18,20,23,26,27,29,30]. One 
study recorded measurements between the hands 
and feet [33]; a method we assumed to be the four 
quadrant method. Seven of the EAV studies reported 
testing for allergies by including ampoules of vari-
ous allergens and control substances in the electri-
cal circuit with the patient [13,17,18,20,26,29,30].
Auricular electrodermal testing is based on the 
work of Paul Nogier who in the 1950s developed an 
acupuncture microsystem on the external ear for 
diagnosing and treating organ pathology in the body 
[44,45]. Several other microsystems exist, including 
the hands and feet, which are studied in the EAV 
system. Nogier originated the concept of a homuncu-
lus (an inverted fetus) on each ear with auricular 
sites that correspond to organs and tissues on the 
entire body. Pathology of a site on the body is be-
lieved to be diagnosable by means of inspection, 
palpation, and electrical skin conductance of rele-
vant zones on the ear. More than 200 acupoints have 
been identified on the ear [46]. In the presence of 
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Figure 1 Each of the 10 domains of information was 
scored between 0−10% in 29 studies for a total possible 
score of 100% for the 10 domains. The information 
domains, depicted on the horizontal axis of this graph, 
are comprised of the 54 subitems listed in Table 1. The 
majority of studies received poor scores (< 35%) for report-
ing three categories (details of the electrode systems, 
technical confounders, and blinding procedures).
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pathology, specific auricular acupoints are said to 
have comparatively higher or lower resistance than 
nearby reference or control sites (anatomically un-
related sites on the homunculus). In the simplest 
form, electrical conductance is measured using an 
ohm meter that applies a small voltage and mea-
sures the current flow or resistance to current 
flow. The reference electrode is held in the pa-
tient’s hand while the probe/stylus is applied by 
an examiner to specific acupoints on the ear. Nine 
of the 29 studies evaluated more than 75 different 
auricular acupoints for confirmation of conditions 
such as musculoskeletal disorders, heart disease, 
cancers, and other internal organ pathologies 
[9,10,21,22,24,25,28,31,34].
Ryodoraku was developed in the 1950s by Yoshio 
Nakatani [1]. The technique consists of measuring 
electrical conductance at representative points 
for each meridian, generally the Yuan (Source) 
points on the wrists and ankles. Because of the 
high variability in skin conductance measurements, 
readings are never taken as absolute but rather as 
relative to all other measurements on the same 
patient and reported on a normalized scale [1]. 
Increased conductance (decreased resistance) is 
believed to represent an excess in the meridian 
being measured, and decreased conductance (in-
creased resistance) represents a deficiency [47]. 
Six of the 29 studies reported using the Ryodoraku 
system [8,14−16,19,32].
Jing-well (Tsing) measurements are based on the 
work of Kobei Akabane, who counted the number of 
strokes of a burning moxa punk across the Jing-well 
point that were required to produce a sensation of 
heat [48]. The number of strokes required was be-
lieved to be inversely correlated with the energy 
level in the meridian, i.e., meridians with deficient 
energy require more strokes before the sensation of 
heat is felt. Since then, Dr. Akabane’s methods have 
been adapted to electronic measurement. Electrical 
resistance measured at the Jing-well (Tsing) points 
is believed to reflect the general energetic balance 
of the meridians. The parameters that are evaluated 
in this system are: left-right asymmetry, yang and 
yin meridian balance, upper and lower body balance, 
and maximum deviation from the mean value of all 
meridians [48]. Two of the 28 studies measured the 
Jing-well acupoints, one of these measured electri-
cal resistance [5] and the other measured electrical 
potentials at these 24 acupoints [12].
3.1.2.  Diagnoses
Medical diagnoses in the 29 studies varied substan-
tially and included respiratory allergy or sensitiv-
ity (n = 5), cancer (n = 5), cocaine abuse (n = 2), 
diabetes (n = 2), and one for each of endometriosis, 
dysmenorrhea, autoimmune disease, internal organ 
disease, tuberculosis, liver disease, food allergy, 
postorthopedic surgery, rheumatoid arthritis, mus-
culoskeletal pain, obesity, coronary artery disease, 
chronic obstructive pulmonary disease, and renal 
colic. Several studies lumped together multiple 
types of cancer [9,14,15,34] or numerous other 
pathologies [17,28,31]. In only one study was an 
acupuncture diagnosis (qi vacuity) made [33].
Recommendations are as follows: Because EDA 
at acupoints was developed to identify energetic 
imbalances rather than western diagnoses defined 
by medical ICD-9 codes, we highly recommend 
that future EDA at acupoints studies report a 
patient’s acupuncture/energetic diagnoses in ad-
dition to their medical diagnoses. We also recom-
mend stricter inclusion/exclusion criteria so that 
there is greater homogeneity in the patients in any 
given study. Exemplary descriptions of medical or 
acupuncture diagnoses and inclusion/exclusion 
criteria are provided in Semizzi et al [26], Saku 
et al [24], and Yu et al [33].
3.1.3.  Study objectives and 
hypotheses
Stated objectives and hypotheses for the 29 stud-
ies include correlating EDA with medical diagnosis 
[14,16−18,20,22,24−30,49], assessing the association 
between EDA at acupoints and clinical outcomes 
[5,13,19], comparing disease-relevant acupoints 
with adjacent skin sites [8,10,21], correlating EDA 
with disease severity [9,12], confirming acupunc-
ture energetic diagnosis [33], correlating EDA with 
histology of auricular points [34], investigating EDA 
at acupoints during weight reduction [32].
Recommendations are as follows: Each of these 
objectives comprises a research question worthy 
of investigation. Researchers studying EDA at acu-
points, however, need to be reminded that large 
questions must be reduced to testable hypotheses 
to derive meaningful information. Researchers’ 
should clearly state their objectives and define 
their hypothesis in the Introduction section of the 
manuscript. There also needs to be a statement of 
how the hypothesis will be statistically tested. 
Examples of clearly stated objectives and hypoth-
eses are found in Falk et al [10], Lewith et al [20], 
Semizzi et al [26], and Yu et al [33].
3.2.  Participants/settings
The number of participants ranged from 14 to 351 
with a mean of 107 (SD ± 81.2). Recruitment meth-
ods, patient demographics, and inclusion/exclusion 
criteria in the majority of studies were inadequately 
reported. Nine studies were performed in hospitals, 
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including surgical suites and emergency depart-
ments, four in clinician’s offices, four in outpatient 
clinics, and three in university departments. In 7 
of the 29 studies, the setting where the research 
was conducted was not described. Rando mization 
procedures were also poorly described in general 
and patient demographics insufficiently explained.
Recommendations are as follows: The recent 
CONSORT statement [50] suggests that a compre-
hensive description of the eligibility criteria that 
were used to select trial participants is needed to 
help readers interpret the study, judge to whom 
the results of a trial apply, and ascertain its rele-
vance to clinical or public health practice. A de-
scription of the method of recruitment, such as by 
referral or self selection (for example, through ad-
vertisements), is also important in this context. 
The nature and stage of the disease being studied 
should be specified. Information on the settings 
and locations is crucial to judge the applicability 
and generalizability of a trial. For example, were 
participants recruited from primary, secondary, or 
tertiary health care or from the community?
Studies conducted by Ahn et al [5], Gerosa et al 
[11], Lewith et al [20], Yu et al [33], and Margolin 
et al [21] provide appropriate descriptions of how 
participants were recruited, the demographics 
of the patient populations, inclusion/exclusion cri-
teria, and the settings where the studies were 
conducted.
3.3.  Skin site selection for bioactive points 
(acupuncture points)
Bioactive points or acupoints were adequately de-
scribed either in the text or with illustrations in 
most studies. Between 4 and 23 acupoints on the 
ears were tested in studies that used the auricular 
approach, whereas practitioners who used the EAV 
approach typically tested between one and 10 skin 
sites on the hands and/or feet. Ryodoraku assess-
ments involved assessing 24 acupoints on the 
wrists and ankles and JingWell studies recorded 
electrical measurements at 24 acupoints on the 
corners of the finger and toe nail beds. One study 
[7] evaluated just two disease-specific acupoints 
(LU 9 and LR 8) in patients with tuberculosis and 
liver dysfunction, respectively.
Recommendations are as follows: Because count-
less acupoints may be tested, a rationale or justifi-
cation needs to be provided for why specific bioactive 
points are chosen. Furthermore, for replication 
purposes a description of the exact anatomical loca-
tions where skin measurements are obtained is vital. 
Margolin et al [21], Tsuei et al [29], and Oleson et al 
[22] each give thorough descriptions and rationales 
for the acupoints they selected.
3.4.  Controls
Of the 29 studies, 26 described having a control 
intervention or population, but the controls varied 
widely and included healthy human volunteers, 
other patient populations, alternate skin sites, 
substances in ampoules, or combinations of humans, 
skin sites, and substances. In 10 studies, healthy 
volunteers, hospital employees, or persons who 
did not have the disease under investigation but 
had other diseases served as controls. Five studies 
used skin sites consisting of non-acupoints or acu-
points that supposedly were not related to the dis-
ease being studied. In several of the EAV studies 
either inert substances, such as normal saline, or 
medications in ampoules were used as controls. In 
some reports, two types of control, healthy volun-
teers plus nonacupoints, or control substances plus 
control skin sites, were employed. Other EAV stud-
ies used a control substance, or a control popula-
tion plus control substances, or a control substance 
and control skin sites.
Recommendations are as follows: A variety of 
controls are appropriate for testing EDA at acu-
points. However, a clear rationale for the particular 
control that is selected needs to be included along 
with a description of the comparisons that are to 
be made in the planned statistical analyses. Semizzi 
et al [26] and Falk et al [10] provide detailed dis-
cussions of their choices of a control (healthy vol-
unteers and physiological saline in the former and 
inactive skin sites in the latter) when using the EAV 
system and the Auricular system, respectively.
3.5.  Electrodes
The electrode systems used in the studies were 
poorly described in general. In only 5 of the 29 re-
search protocols were the electrode systems de-
scribed in enough detail to build or purchase a similar 
system [10,21,23,26,28]. However, even in those 
higher quality studies, a description of whether the 
measurement system had been validated and how 
electrodes were calibrated prior to use in the study 
was reported in only two [10,23].
Recommendations are as follows: Standards for 
measuring skin conductance were first recommended 
in 1971 [38] and then adopted by the official journal 
of the Society for Psychophysiological Research in 
1981 [37]. No such standards have been developed 
for EDA at acupoints research. It will be a chal-
lenge to develop standards in this area of research 
because of the many approaches in current use. 
Consequently it is vital that researchers provide an 
exact description of the electrode system and the 
number and type of electrodes used, including size, 
shape, materials, and conductive interfaces so that 
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study replication is possible and methodological 
standards can evolve for each of the EDA at acupoints 
approaches. Prokhorov et al [23] present an exem-
plary description of the electrode system they used.
3.6.  Confounding variables
Electrical skin measurements at acupoints are gen-
erally believed to be unreliable because they are 
confounded by artifacts created by lesions or 
moisture on the skin surface, inadequate skin 
preparation, type and placement of the reference 
electrode, problems at the probe-skin interface, 
skin probe pressure variability, contact impedance 
and polarization at the probe tip, as well as the 
influences of repeating measurements [36]. These 
factors substantially affect the accuracy and repeat-
ability of EDA measurements and yet, only three of 
the 29 studies reported on how these issues were 
addressed [10,21,23]. The average reporting score 
for this category of essential information was 20% 
suggesting that this domain of information needs 
particular attention in future studies.
Recommendations are as follows: Ahn et al [36] 
elaborated on the technical challenges associated 
with recording electrical characteristics at acu-
points. Because the confounders in EDA research 
are so pervasive and significantly affect the accuracy 
and reliability of electrodermal measurements, it 
is essential that the equipment, methodology, and 
procedures be tested for precision and reliability 
prior to conducting an actual clinical trial. Fur-
thermore, to allow replication, how each potential 
problem is to be addressed in the study design also 
needs to be itemized. Margolin et al [21] provide 
an enlightening discussion of how they handled 
confounding variables in their study.
3.7.  Instrumentation and electrical 
parameters
Four distinct electrical parameters were measured 
in these 29 studies. Skin conductance (or admit-
tance), skin resistance (or impedance), skin capac-
itance, and skin potentials. Almost 2/3 EDA at 
acupoint researchers (n = 18) measured resistance 
or conductance using a simple DC system. Three 
studies used an alternating current system (AC) to 
measure impedance (or admittance) [10,21,24]. 
One study measured skin capacitance [23] and one 
measured electrical skin potentials [12]. Reporting 
in many studies, however, was often ambiguous or 
confusing, making it difficult to interpret results. 
With no clear explanation that such a process had 
occurred, some researchers measured electrical 
resistance, then transformed the resistance values 
(kohms) to conductance (mhos or Siemens), then 
further converted the conductance values to nor-
malized units which were reported on scales of 
0−40, 0−100, or 0−200. These disparate ways of re-
porting make it difficult to compare one study’s 
findings to another. Direct skin conductance re-
cording using a constant voltage system is recom-
mended for psychophysiologi cal research when 
evaluating autonomic responsiveness [37,38]. Direct 
skin conductance measurements alone, however, 
may not be appropriate for evaluating EDA at acu-
points. It has been suggested that although elec-
trical capacitance measurements at acupoints are 
infrequently evaluated, this parameter may offer 
insights into the character of acupoints and merid-
ians and its measurement should be considered in 
future studies [42,51,52].
Recommendations are as follows: At this na-
scent stage of EDA at acupoints research, we cannot 
recommend definitive standards for instrumenta-
tion and electrical measurements. We do, how-
ever, encourage authors to report the details of 
their instrumentation, explaining exactly how the 
instrument makes its measurements, what electri-
cal parameters are measured, why those parameters 
are chosen, and what units are finally reported. An 
example of excellent reporting of instrumentation 
and electrical parameters is found in Prokhorov 
et al [23].
3.8.  Measurements
The Measurement information domain refers to 
electrical outcomes, the number and duration of 
electrical measurements, laboratory conditions 
under which testing was performed, accounts of 
temporal variability, emotion, time of day, noise, 
movement and hydration, and whether the equip-
ment was evaluated for interuser reliability. This 
information was poorly reported in general with 
only seven of the 29 studies receiving a grade of 
60% or greater in reporting these parameters.
Recommendations are as follows: The accuracy 
and reliability of the instrument in taking its mea-
surements, laboratory conditions, and the variability 
among different operators using the same instrument 
substantially impacts the scientific validity of the 
experiment. Careful attention should be paid to these 
technical and procedural issues when conducting and 
reporting a clinical trial. An example of excellent 
reporting in which measurement conditions were 
well defined and the overall quality of the measur-
ing techniques attended to is found in Falk et al [10].
3.9.  Blinding
The mean score for how researchers reported their 
blinding procedures for EDA testing or whether 
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those blinding procedures were successful was 30% 
with none of the 29 studies scoring greater than 50%.
Recommendations are as follows: We highlight 
the recommendations of Day and Altman who stress 
the special need for blinding in studies of diagnostic 
accuracy [53]. They state that blinding to diagnosis 
of persons who perform a diagnostic test and of 
those assessing the results is particularly impor-
tant in view of the potential for subconscious bias 
when the tester knows the diagnosis. It is also im-
portant when evaluating the reproducibility of a 
measurement technique that observers be unaware 
of their previous measurement(s) on the same in-
dividual. On average, diagnostic test performance 
is overestimated when the reference test is inter-
preted with knowledge of the test result.
3.10.  Results/statistical analysis
In this review we did not judge the validity of the 
statistical methods or results, nor did we assess 
whether the statistical analyses were appropriate for 
the study design or for the parameters being eval-
uated. We merely determined whether the results 
and statistical analysis were reported in enough de-
tail to permit verification. Twenty out of 29 studies 
provided sufficient details of the statistical analysis 
for verification of the study’s results.
Recommendations are as follows: The updated 
CONSORT statement acknowledges that data can 
be analyzed in many ways, some of which may not be 
strictly appropriate in a particular situation [50]. 
It is essential to specify which statistical proce-
dure was used for each analysis. They suggest the 
principle to follow is, ‘‘Describe statistical methods 
with enough detail to enable a knowledgeable reader 
with access to the original data to verify the re-
ported results’’ [50]. Four studies, Ahn et al [5], 
Falk et al [10], Margolin et al [21], and Semizzi et al 
[26], provide summary data and descriptive and 
interferential statistics in sufficient detail to permit 
alternative analyses and replication [40].
4.  Discussion
Evaluation of the quality of reporting in 29 studies 
that tested the clinical utility of EDA at acupoint 
measurements revealed a marked inadequacy in 
reporting essential methodological details. Notably 
deficient were descriptions of how confounding var-
iables that influence the accurate recording of EDA 
measurements were addressed, which blinding pro-
cedures were implemented, and the details of the 
types of electrode systems that were used. Only 9 of 
the 29 papers [5,10,17,20−23,26,33] provided enough 
information on the protocol and methodologies 
used to qualify for inclusion in a future systematic 
review that will answer the question, “Is there evi-
dence to support the use of EDA at acupoints as an 
aid to diagnosis and/or therapeutic monitoring?”
To rigorously build a program of research on 
EDA at acupoints there is a need to standardize re-
search methods and reporting protocols. An impor-
tant goal in future publications should be to provide 
sufficient detail to conform to the quality expected 
by scientific journals. Such publications will in turn 
attract the attention of a broader range of scien-
tists. We recommend that the 10 broad categories 
of information and the 54 subitems listed in Table 1 
be evaluated and reported in future EDA at acupoints 
studies.
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